| Time After Starting | Time After Stopping | ALT (U/L) | Alk P (U/L) | Bilirubin (mg/dL) | Other |
|---|---|---|---|---|---|
| Pre | Pre | 25 | 100 | 0.2 | |
| 0 | Pre | 22 | 98 | 0.2 | Pazopanib started |
| 2 weeks | Pre | 30 | 89 | 0.3 | INR 1.1 |
| 6 weeks | 0 | 759 | 729 | 6.3 | Pazopanib stopped |
| 7 weeks | 1 | 166 | 523 | 10.4 | INR 1.1 |
| 8 weeks | 2 weeks | 55 | 426 | 15.7 | Liver biopsy |
| 9 weeks | 3 weeks | 38 | 381 | 22.9 | |
| 10 weeks | 4 weeks | 34 | 437 | 18.6 | INR 1.8 |
| 11 weeks | 5 weeks | 29 | 484 | 14.9 | INR 1.7 |
| 15 weeks | 9 weeks | 28 | 484 | 13.0 | Death |
| Normal Values | Not given | Not given | <1.2 | ||
From: Pazopanib
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.